In HNSCCs, combined single-cell RNA sequencing and multiplex immunofluorescence recently identified a new tumour-infiltrating cell (TIL) subtype, CD103+ CD8+ TILs, associated with clinical response. This evidence concerns the gene CD8A and neoplasm.